Effects of methylphenidate on neuropsychiatric symptoms in Alzheimer's disease: Evidence from the ADMET 2 study

INTRODUCTION: Methylphenidate has been shown to improve apathy in patients with Alzheimer's disease (AD). The authors evaluated the impact of methylphenidate on neuropsychiatric symptoms (NPS) of AD, excluding apathy, using data from the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2) stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Clark, Emily D., Perin, Jamie, Herrmann, Nathan, Brawman‐Mintzer, Olga, Lanctôt, Krista L., Lerner, Alan J., Mintzer, Jacobo, Padala, Prasad R., Rosenberg, Paul B., Sami, Susie, Shade, David M., van Dyck, Christopher H., Porsteinsson, Anton P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394740/
https://www.ncbi.nlm.nih.gov/pubmed/37538343
http://dx.doi.org/10.1002/trc2.12403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394740/
https://www.ncbi.nlm.nih.gov/pubmed/37538343
http://dx.doi.org/10.1002/trc2.12403

Ejemplares similares